Skip to content
Clinical Trials – home
GermanyBack to Germany

Clinical trials in Landshut – page 2

36 clinical trials in Landshut, Germany. Every trial is listed in the EU Clinical Trials Register and updated daily.

GermanyOur site in GermanyKlinischeStudien.de(opens in a new tab)
Landshut at a glance
36
clinical trials
  • Paediatric trials0
  • Research sites0
Type of trial
Recruitment status
Quick filters

36 trials in Landshut

Open in trial search
Countries:GermanyGermany
  • Participants:18–64 years · 65+ years
  • Substances:Tislelizumab
  • Sponsor:University Of Cologne
Countries:GermanyGermany
  • Participants:18–64 years · 65+ years
  • Substances:Obinutuzumab
  • Sponsor:AbbVie Deutschland GmbH & Co. KG
Countries:GermanyGermany
  • Participants:18–64 years · 65+ years
  • Substances:Anastrozole
  • Sponsor:Institut fuer Frauengesundheit GmbH
Countries:GermanyGermany
  • Participants:18–64 years · 65+ years
  • Substances:Anastrozole
  • Sponsor:AstraZeneca AB
Countries:GermanyGermany
  • Participants:18–64 years · 65+ years
  • Substances:Bevacizumab
  • Sponsor:Charite Universitaetsmedizin Berlin KöR
Countries:GermanyGermany
  • Participants:18–64 years · 65+ years
  • Substances:Calcium Folinate
  • Sponsor:Charite Universitaetsmedizin Berlin KöR
Countries:GermanyGermany
  • Participants:18–64 years · 65+ years
  • Substances:Cetuximab
  • Sponsor:Charite Universitaetsmedizin Berlin KöR
Countries:GermanyGermany
  • Participants:18–64 years · 65+ years
  • Substances:Fluorouracil
  • Sponsor:Fondation Franc.Cancerologie Digestive
Countries:GermanyGermany
  • Participants:18–64 years · 65+ years
  • Substances:Docetaxel
  • Sponsor:Frankfurter Institut Fuer Klinische Krebsforschung IKF GmbH
Countries:GermanyGermany
  • Participants:18–64 years · 65+ years
  • Substances:Luspatercept
  • Sponsor:Universitaet Leipzig
Countries:GermanyGermany
  • Participants:18–64 years · 65+ years
  • Substances:Capecitabine
  • Sponsor:GBG Forschungs GmbH
Countries:GermanyGermany
  • Participants:18–64 years · 65+ years
  • Substances:Rituximab
  • Sponsor:Universitaetsklinikum Ulm AöR

Other cities in Germany

The busiest research cities in the country

All 515 cities in Germany

Clinical research in Landshut

What the registry says about research in the country

01 Hematologic Oncology

Groundbreaking research focusing on chronic lymphocytic leukemia and various lymphomas, including innovative combination therapies and targeted treatments for elderly patients.

  • Advanced treatment strategies for Waldenström's Macroglobulinemia
  • Novel therapies for Hodgkin and Non-Hodgkin Lymphomas
  • Personalized approaches for leukemia management

Multiple trials evaluating BTK inhibitors and immunotherapy combinations.

02 Gastrointestinal Oncology

Comprehensive studies investigating treatments for colorectal cancer and gastroesophageal conditions, with emphasis on preoperative and adjuvant therapies.

  • Advanced stage colon cancer treatments
  • Metastatic colorectal cancer management
  • Gastroesophageal junction adenocarcinoma therapies

Focus on innovative surgical approaches and targeted molecular therapies.

03 Breast Cancer Research

Studies examining novel treatments for HER2-negative breast cancer, including immunotherapy and targeted therapeutic approaches.

  • Advanced hormone receptor-positive breast cancer
  • Innovative combination therapies
  • Extended adjuvant treatment strategies

Emphasis on personalized medicine and molecular profiling approaches.

Clinical Trials Concierge

Prefer not to search? Our Concierge searches the trials for you.

Tell us about your condition – we search every trial in Europe and connect you with the right site.